IPO Guru

IPO Listed — 29 Jun 2026

Listing Price: ₹136.2 (-10.39% vs ₹152)

View GMP History →
Turtlemint Fintech Solutions

Turtlemint Fintech Solutions IPO Review

Turtlemint Fintech Solutions IPO has been reviewed by 10 analysts, and the overall consensus is Avoid — carrying a score of 43. Out of the 10 analysts who have covered this IPO, 4 recommend subscribing while 6 advise caution or avoidance — reflecting a cautious view from the analyst community.

The issue is priced in the band of ₹144-152 per share , with a minimum application size of 98 shares (minimum investment of approximately ₹14,896 at the upper band) . Subscription ran from 19 Jun 2026 to 23 Jun 2026. As of now, the grey market premium (GMP) for Turtlemint Fintech Solutions IPO is quoting at ₹-5 (-3.3%), which gives a preliminary sense of how the street is pricing the listing — though GMP is unofficial and can swing sharply before the listing date. Scroll down for the full analyst breakdown and analyst-wise verdicts.

General Review

Turtlemint runs an insurance distribution technology platform. Revenue scaled rapidly, from ₹119.12 crore in FY24 to ₹693.21 crore in FY25 and ₹748.91 crore for the nine months to December 2025, but the company remains loss-making at every level. Opinion was evenly split: four analysts said subscribe and four said avoid.

Listing Gains

With no profit, the notes value the issue on revenue, at roughly 6.8 times FY25 revenue on a market cap of ₹4,275 to ₹4,476 crore. Analysts point out the only listed Indian comparable trades at 15.3 times revenue but is profitable. The even split in ratings pointed to a muted listing.

Short Term Strategy

Losses have not narrowed, running at ₹193.35 crore, ₹194.11 crore and ₹187.39 crore across the three periods, with negative RoNW of 47.29 percent. One note calls this unambiguously a pre-profitability business. Near-term, the coverage saw no visible path to profit, which is what drove the avoid ratings.

Long Term Strategy

The positive notes argue the platform is maturing and that revenue scale will eventually bring operating leverage in a large, underpenetrated insurance distribution market. The opposing view is that the risk-reward is unfavourable while losses persist at this size. Long-term merit therefore hinges entirely on when losses turn.

Disclaimer: This review is an AI summary derived from the reviews of all analysts.

Analyst Sentiment

Analytical Score

How it's calculated?
Avoid
43 / 100

Recommend Subscribe

Based on 10 analyst reviews

4 / 10

Higher consensus indicates broader analyst agreement.

Analyst Review

Latest IPO Reviews

Frequently Asked Questions

Should I apply for Turtlemint Fintech Solutions IPO?

Based on analyst coverage tracked on this page, the overall verdict for Turtlemint Fintech Solutions IPO is Avoid. Out of 10 analysts who have reviewed this IPO, 4 recommend subscribing. Always cross-check with the full analyst reviews below and consult a SEBI-registered advisor before making any investment decision.

What does the score of 43 mean for Turtlemint Fintech Solutions IPO?

The score of 43 is an aggregate of all analyst ratings tracked for Turtlemint Fintech Solutions IPO. A score in this range reflects mixed views — some analysts are positive while others are cautious. Scroll down to read individual analyst verdicts for more context.

What was the actual listing price of Turtlemint Fintech Solutions IPO?

Turtlemint Fintech Solutions IPO listed on June 29, 2026 at ₹136.2 , against the issue price of ₹152 — a loss of -10.39% (₹15.8 per share). View the full GMP history page for day-wise pre-listing trends.

What is the price band and lot size of Turtlemint Fintech Solutions IPO?

Turtlemint Fintech Solutions IPO was priced at ₹144-152 per share. The minimum lot size is 98 shares, making the minimum investment approximately ₹14,896 at the upper end of the price band. Subscription ran from 19 Jun 2026 to 23 Jun 2026.

Explore Turtlemint Fintech Solutions IPO Further

Track every stage of this IPO:

Advertisement
Disclaimer: Grey Market Premium (GMP) is for information purposes and is not a guarantee of listing price. Always consult your financial advisor before investing.